Chronic obstructive pulmonary disease (COPD) is a medical condition that affects around 4% of the general population. Bronchitis, emphysema, cystic fibrosis, and asthma all can contribute to COPD. The main contributing factor to COPD is cigarette and tobacco smoking. More than 3 million people die from COPD each year, and 90% of these deaths occur in low- and middle-income countries. According to the World Health Organization, COPD is the fifth leading cause of death.
Several chemical mechanisms influence the typical progressive nature of chronic obstructive pulmonary disease. The latest innovative treatment for COPD is stem cell therapy, where the patient’s own cells are infused or transplanted back into the body. Procedures include obtaining the stem cells from fat tissue (adipose) during liposuction, processing them in the lab, and delivered back into the patient. The patient receives around 250 million stem cells per one autologous stem cell therapy session.
Stem cell treatment for COPD and lung disease is now a reality and being offered for patient benefit. The results have been stellar, which is great because there really is no surgical option available!
Stem cell therapy has been proven to work in several studies. A few examples include:
Amniotic and Umbilical Cord Stem Cell Treatments